Lithium Versus Lamotrigine in Bipolar Disorder, Type II

计划入组 200 人 · 首次发布于 2023 年 12 月 28 日

rTMS for Treatment of Depressed Phase of Bipolar Disorder Type II

首次发布于 2007 年 3 月 14 日

Vortioxetine Adjunctive Treatment in Bipolar Depression

计划入组 131 人 · 首次发布于 2022 年 8 月 1 日

small molecule therapeutics (bipolar disorder)

H TYPE II TRISACCHARIDE

C₂₀H₃₅NO₁₅

Bipolar disorders(Unravel Biosciences)

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Celgene International II SARL

Switzerland

Meiragtx UK II Ltd.

Belgium

GH Research Awaits Phase 2b Topline Data for GH001 in Treatment-Resistant Depression

Bipolar Disorder Pipeline Shows Promise with 22+ Emerging Therapies

Biohaven's BHV-7000 Fails Primary Endpoint in Pivotal Bipolar Disorder Trial